van de Loo FA - Search Results

1

Amelioration of established murine collagen-induced arthritis with anti-IL-1 treatment.

van den Berg WB, Joosten LA, Helsen M, van de Loo FA. van den Berg WB, et al. Among authors: van de loo fa. Clin Exp Immunol. 1994 Feb;95(2):237-43. doi: 10.1111/j.1365-2249.1994.tb06517.x. Clin Exp Immunol. 1994. PMID: 8306498 Free PMC article.

2

Higher efficacy of anti-IL-6/IL-21 combination therapy compared to monotherapy in the induction phase of Th17-driven experimental arthritis.

Roeleveld DM, Marijnissen RJ, Walgreen B, Helsen MM, van den Bersselaar L, van de Loo FA, van Lent PL, van der Kraan PM, van den Berg WB, Koenders MI. Roeleveld DM, et al. Among authors: van der kraan pm, van lent pl, van de loo fa, van den bersselaar l, van den berg wb. PLoS One. 2017 Feb 3;12(2):e0171757. doi: 10.1371/journal.pone.0171757. eCollection 2017. PLoS One. 2017. PMID: 28158305 Free PMC article.

3

Animal models of arthritis in NOS2-deficient mice.

van den Berg WB, van de Loo F, Joosten LA, Arntz OJ. van den Berg WB, et al. Osteoarthritis Cartilage. 1999 Jul;7(4):413-5. doi: 10.1053/joca.1999.0228. Osteoarthritis Cartilage. 1999. PMID: 10419784 Free article.

4

Protection against cartilage proteoglycan synthesis inhibition by antiinterleukin 1 antibodies in experimental arthritis.

van de Loo FA, Arntz OJ, Otterness IG, van den Berg WB. van de Loo FA, et al. Among authors: van den berg wb. J Rheumatol. 1992 Mar;19(3):348-56. J Rheumatol. 1992. PMID: 1578447

5

Chondrocyte nonresponsiveness of arthritic articular cartilage caused by short term immobilization.

van Lent PL, van de Loo FA, van den Bersselaar L, van den Berg WB. van Lent PL, et al. Among authors: van de loo fa, van den bersselaar l, van den berg wb. J Rheumatol. 1991 May;18(5):709-15. J Rheumatol. 1991. PMID: 1865417

6

In vivo evidence for a key role of IL-1 in cartilage destruction in experimental arthritis.

van den Berg WB, van de Loo FA, Otterness I, Arntz O, Joosten LA. van den Berg WB, et al. Among authors: van de loo fa. Agents Actions Suppl. 1991;32:159-63. doi: 10.1007/978-3-0348-7405-2_21. Agents Actions Suppl. 1991. PMID: 2069084 Review.

7

Role of IL-2 and IL-4 in exacerbations of murine antigen-induced arthritis.

Jacobs MJ, van den Hoek AE, van Lent PL, van de Loo FA, van de Putte LB, van den Berg WB. Jacobs MJ, et al. Among authors: van de putte lb, van lent pl, van den hoek ae, van de loo fa, van den berg wb. Immunology. 1994 Nov;83(3):390-6. Immunology. 1994. PMID: 7835964 Free PMC article.

8

Role of interleukin-1, tumor necrosis factor alpha, and interleukin-6 in cartilage proteoglycan metabolism and destruction. Effect of in situ blocking in murine antigen- and zymosan-induced arthritis.

van de Loo FA, Joosten LA, van Lent PL, Arntz OJ, van den Berg WB. van de Loo FA, et al. Among authors: van lent pl, van den berg wb. Arthritis Rheum. 1995 Feb;38(2):164-72. doi: 10.1002/art.1780380204. Arthritis Rheum. 1995. PMID: 7848306

9

Early cartilage degradation in cationic immune complex arthritis in mice: relative role of interleukin 1, the polymorphonuclear cell (PMN) and PMN elastase.

van Lent PL, van den Hoek AE, van den Bersselaar LA, van de Loo FA, Eykholt HE, Brouwer WF, van de Putte LB, van den Berg WB. van Lent PL, et al. Among authors: van den bersselaar la, van de putte lb, van den hoek ae, van de loo fa, van den berg wb. J Rheumatol. 1994 Feb;21(2):321-9. J Rheumatol. 1994. PMID: 8182644

10

Modulation of cartilage destruction in murine arthritis with anti-IL-1 antibodies.

van de Loo FA, Arntz OJ, Otterness IG, van den Berg WB. van de Loo FA, et al. Among authors: van den berg wb. Agents Actions. 1993;39 Spec No:C211-4. doi: 10.1007/BF01972769. Agents Actions. 1993. PMID: 8273572

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

191 results

Search Page